Please login to the form below

Not currently logged in
Email:
Password:

Omotys

This page shows the latest Omotys news and features for those working in and with pharma, biotech and healthcare.

Affymax in a tailspin after Omontys recall

Affymax in a tailspin after Omontys recall

Makes heavy job cuts in face of bankruptcy threat

Latest news

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics